Cargando…

Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis

Background: Currently, there is no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disorder. Many biomarkers have been proposed, but because ALS is a clinically heterogeneous disease with an unclear etiology, biomarker discovery for ALS has been challengi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Xin, Cheng, Huo, Jia, Li, Xin, Dong, Hui, Liu, Qi, Li, Rui, Liu, Yaling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670085/ https://www.ncbi.nlm.nih.gov/pubmed/38002490 http://dx.doi.org/10.3390/brainsci13111531

Ejemplares similares

Development and validation of a dynamic risk prediction system for constipation in patients with amyotrophic lateral sclerosis
por: Niu, Tongyang, et al.
Publicado: (2022)

Sleep Disturbances as a Potential Risk Factor for Deterioration of Respiratory Function in Patients with Amyotrophic Lateral Sclerosis
por: Li, Xin, et al.
Publicado: (2023)

The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
por: Zhao, Jiantao, et al.
Publicado: (2022)

Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis
por: Dudman, Jessica, et al.
Publicado: (2020)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
por: Liu, Jinmeng, et al.
Publicado: (2022)

Progress in Therapy Development for Amyotrophic Lateral Sclerosis
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy
por: Williamson, R. T.
Publicado: (1907)

Predicting disease progression in amyotrophic lateral sclerosis
por: Taylor, Albert A., et al.
Publicado: (2016)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Amyotrophic Lateral Sclerosis and Primary Biliary Cirrhosis Overlap Syndrome: Two Cases Report
por: Zhang, Haibo, et al.
Publicado: (2019)

Geranylgeranyltransferase I is essential for dendritic development of cerebellar Purkinje cells
por: Wu, Kong-Yan, et al.
Publicado: (2010)

Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2013)

Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
por: Du, Hongmei, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)

Anthropometry of Arm: Nutritional Risk Indicator in Amyotrophic Lateral Sclerosis
por: Salvioni, Cristina Cleide dos Santos, et al.
Publicado: (2015)

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis
por: Liu, Zhi-Jun, et al.
Publicado: (2019)

Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis
por: Kasai, Atsushi, et al.
Publicado: (2011)

Erratum to “Progress in Therapy Development for Amyotrophic Lateral Sclerosis”
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
por: Calvo, Ana C., et al.
Publicado: (2014)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Histaminergic transmission slows progression of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2019)

Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020)

Modeling Amyotrophic Lateral Sclerosis Progression: Logic in the Logit
por: Shaabi, Afaf
Publicado: (2022)

Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis
por: Galbiati, Mariarita, et al.
Publicado: (2020)

Discontiguous or Contiguous Spread Patterns Affect the Functional Staging in Patients With Sporadic Amyotrophic Lateral Sclerosis
por: Zhenfei, Li, et al.
Publicado: (2019)

Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis
por: Jiang, Xin, et al.
Publicado: (2021)

Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy
por: Wang, Hui, et al.
Publicado: (2023)

Phosphoinositide-3-kinase regulatory subunit 4 participates in the occurrence and development of amyotrophic lateral sclerosis by regulating autophagy
por: Liu, Yue, et al.
Publicado: (2021)

Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis
por: Gong, Zhenxiang, et al.
Publicado: (2022)

Different sensorimotor mechanism in fast and slow progression amyotrophic lateral sclerosis
por: Li, Qianwen, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_71igsl0bgsi9qa3r1asir7hlkh